Pharmstandard International S.A.

13F Filings History

Latest 13F report
Q3 2018 - Nov 15, 2018
Value $
$29M
Signature - Title
Eriks Martinovskis - Director
Location
Luxembourg, Luxembourg
Summary
This page shows a list of all the recent 13F filings made by Pharmstandard International S.A.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Pharmstandard International S.A. reported 6 stock holdings with total value $29M as of Q3 2018. Top holdings included ALNAQ, PTGX, NTGN, JNCE, and PRTO.
Holdings Value